Filing Flows › Scilex Holding (SCLX) › R&D spending
Scilex Holding (SCLX) R&D spending by quarter
Scilex Holding's R&D spending was $3.3M in Q2 2026 (second quarter 2026), +4% from Q1 2026. Over the last 7 quarters it ranged from $2.2M (Q4 2024) to $8.2M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.3M | +4% | -46% |
| Q1 2026 | $3.2M | -61% | +31% |
| Q4 2025 | $8.2M | +109% | +275% |
| Q3 2025 | $3.9M | -37% | — |
| Q2 2025 | $6.2M | +152% | — |
| Q1 2025 | $2.5M | +13% | — |
| Q4 2024 | $2.2M | — | — |
Q2 2026 at a glance
Scilex Holding, Q2 2026: revenue $7.6M (-23% year over year), operating margin -385.0%, net loss $115M, operating cash flow −$6.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Scilex Holding's R&D spending?
Scilex Holding's R&D spending was $3.3M in Q2 2026 (second quarter 2026), +4% from Q1 2026.
How has Scilex Holding's R&D spending changed?
Over the last 7 quarters it ranged from $2.2M (Q4 2024) to $8.2M (Q4 2025).